Cybersecurity strategy and scope
Clarify the device boundary, intended use, data flows, connections, service paths, and ownership needed to keep cybersecurity work proportionate and actionable.
Talk to an expertMEDICAL DEVICE CYBERSECURITY CONSULTING
Build cybersecurity into the device, the evidence, and the support model, before a late discovery turns into a submission, quality, or patient-safety problem.
Discuss your cybersecurity program →
SECURITY THAT FITS THE DEVICE
For a medical device, a cybersecurity decision can affect more than data protection. It can affect safe use, essential performance, availability, service continuity, software updates, clinical workflow, and the evidence that supports a regulatory filing. The risk is rarely contained in one application or one team. It moves across the device, its accessories, the people who support it, and the systems around it.
Qualira helps teams turn that complexity into a practical, device-specific cybersecurity program. The work connects architecture, intended use, threat scenarios, design controls, risk management, verification, quality records, and post-market responsibilities so the team can make clear decisions without creating a parallel process that nobody can maintain.
WHERE QUALIRA HELPS
Clarify the device boundary, intended use, data flows, connections, service paths, and ownership needed to keep cybersecurity work proportionate and actionable.
Identify realistic attack paths and connect them to potential safety, performance, data, and availability consequences in the device risk record.
Align requirements, architecture, testing, findings, residual risk, software information, and technical documentation so the supporting record tells one story.
Build a repeatable way to assess reported issues, decide on action, verify changes, coordinate communications, and maintain control after launch.
FROM SYSTEM BOUNDARY TO LIFECYCLE SUPPORT
Connected-device cybersecurity becomes expensive when it is treated as a final test instead of an engineering, clinical, and quality decision. A service port added for maintenance, a cloud connection, a new wireless workflow, or a third-party software component can each change the ways a device might be accessed or affected. If those decisions are not visible early, the team may discover gaps only after key architecture, verification, or submission work has already been set.
Qualira starts by helping teams see the real system boundary. That means looking beyond the device itself to the interfaces, accessories, service tools, data paths, update methods, manufacturing and support environments, and people who operate or maintain the product. The goal is not to make the scope as broad as possible. It is to identify the paths that matter to the device and use environment, then give each risk a clear owner and a proportionate response.
Threat modeling gives that work structure. It allows the team to examine what assets need protection, what an attacker could realistically reach, what could happen if a control fails, and how that event may affect safe or effective use. Those findings need to stay connected to the device risk-management process. A technical weakness matters differently when it could affect therapy delivery, diagnosis, alarm behavior, stored data, clinical operations, or the ability to recover the product safely.
The next challenge is evidence. Cybersecurity requirements, architecture decisions, test plans, verification records, vulnerability findings, and user or service documentation often come from different contributors. A credible program makes the relationships traceable. It shows how important risks were considered, which controls were chosen, how they were tested, what remains, and how the organization will respond when the product or its environment changes.
That is equally important after market entry. New vulnerabilities, software components, service methods, and external threats do not pause because a device has launched. A usable response process helps the organization determine whether an issue affects a product version or configuration, evaluate the device-specific consequence, decide whether mitigation or a controlled update is appropriate, verify the change, and maintain a clear record of the decision. The result is a program that can respond deliberately instead of scrambling for facts under pressure.
WHAT A USEFUL ENGAGEMENT CLARIFIES
Cybersecurity work is strongest when it gives the team decisions they can act on, rather than a long list of generic controls. The practical questions are where the product is exposed, what that exposure could mean for the device and its users, which controls are justified, and what evidence shows the decision has been carried through.
Qualira can work alongside product, software, systems engineering, quality, regulatory, clinical, service, and leadership teams. Some programs need a complete plan from architecture through readiness. Others need an independent review, targeted help on a security finding, or added senior capacity when a critical change is in motion.
The device is often part of a larger ecosystem. Defining the relevant interfaces, assets, users, maintenance paths, and dependencies helps prevent important attack paths from being missed or irrelevant work from consuming the team.
A cybersecurity scenario needs to be evaluated in the context of the product and its use. Qualira helps connect technical findings to potential safety, performance, availability, and clinical consequences so risk decisions remain meaningful.
Architecture, requirements, controls, test results, residual risk, software information, and lifecycle plans should support the same rationale. A clear record reduces ambiguity when the program reaches a major review or a change needs to be explained.
Post-market cybersecurity requires a repeatable decision path, not a reaction to every alert. Qualira can help define practical intake, assessment, escalation, remediation, verification, and communication steps that fit the device and organization.
PRACTICAL, CROSS-FUNCTIONAL SUPPORT
Cybersecurity programs lose momentum when a finding becomes a technical issue for one group and a quality or regulatory issue for another. Qualira helps teams create a shared view of the device, its risks, and the evidence behind the chosen controls. That makes it easier to decide what needs to change, what needs to be documented, and who needs to act before a small gap becomes a larger program problem.
This approach is especially useful for teams preparing a connected product for a major milestone, integrating new software or third-party components, responding to a reported vulnerability, or strengthening the processes that will support the device after launch. The work stays tied to the product and the decision at hand, not a generic security checklist.

A USEFUL FIRST CONVERSATION
Which device interfaces, service paths, updates, data flows, and external systems need to be in our cybersecurity scope?
Where are threat modeling, engineering controls, risk management, verification, and documentation falling out of alignment?
What evidence needs to be ready before a regulatory milestone, design change, or connected-product launch?
Do we need a full cybersecurity program, a targeted readiness review, or focused support for an active vulnerability?
FREQUENTLY ASKED QUESTIONS
The strongest time is while the device architecture, intended use, connectivity, data flows, and service model can still be influenced. Support can also be valuable when a team is preparing for a submission, responding to a vulnerability, evaluating a major change, or adding capacity for a focused review.
Yes. Cybersecurity risk can arise through wireless connections, USB ports, removable media, service tools, software updates, connected accessories, hospital networks, cloud services, and the clinical environment around the device. The relevant question is how the device can be accessed, maintained, or affected in real use.
Yes. Qualira can help connect system architecture, threat modeling, cybersecurity requirements, risk management, verification evidence, vulnerability management, and submission documentation into a coherent device-specific record. The work is shaped around the device, its intended use, and the regulatory path in front of the program.
No. A software bill of materials helps a team identify components that may be affected by a reported issue, but it does not determine whether the issue is reachable, exploitable, or clinically meaningful for a specific device. A documented assessment and a proportionate response process are still needed.
Yes. A focused response can clarify the product versions and configurations affected, evaluate device-specific risk, identify practical containment or remediation options, define the evidence needed for a change, and coordinate quality, regulatory, engineering, service, and customer-facing decisions.
TALK WITH QUALIRA